Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks

Future Science OA

Volumn 2, Issue 2, 2016, Pages

  Moussa, Hind N ^a   Hosseini Nasab, Susan ^a   Haidar, Ziad A ^a   Blackwell, Sean C ^a   Sibai, Baha M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

adverse pregnancy outcomes; folic acid; pre conception supplement

Indexed keywords

CARBAMAZEPINE; FOLIC ACID; PHENYTOIN; VALPROIC ACID;

ALLERGIC REACTION; ANEMIA; ASTHMA; AUTISM; BODY WEIGHT DISORDER; CARDIOVASCULAR MALFORMATION; CHEMICAL TERATOGENESIS; CHILDHOOD CANCER; CONCEPTION; FETAL HYDANTOIN SYNDROME; FETUS OUTCOME; FOLIC ACID DEFICIENCY; GASTROINTESTINAL DISEASE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MALARIA; METABOLIC DISORDER; NEURAL TUBE DEFECT; NEUROLOGIC DISEASE; NEUROTOXICITY; PERNICIOUS ANEMIA; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEIZURE; TWIN PREGNANCY; VITAMIN SUPPLEMENTATION;

EID: 85032039732     PISSN: None     EISSN: 20565623     Source Type: Journal    
DOI: 10.4155/fsoa-2015-0015     Document Type: Review

References (97)

1. Centers for Disease Control and Prevention (CDC). Spina bifida and anencephaly before and after folic acid mandate -United States, 1995-1996 and 1999-2000. MMWR Morb. Mortal. Wkly Rep. 53, 363-365 (2004
2. Greene ND, Stanier P, Moore GE. The emerging role of epigenetic mechanisms in the etiology of neural tube defects. Epigenetics 6(7), 875-883 (2011
3. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338(8760), 131-137 (1991
4. Centers for Disease Control and Prevention (CDC). Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm. Rep. 41, 1-7 (1992
5. Crane NT, Wilson DB, Cook DA, Lewis CJ, Yetley EA, Rader JI. Evaluating food fortification options: general principles revisited with folic acid. Am. J. Public Health 85(5), 660-666 (1995
6. Food and Drug Administration. Authors Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final Rule. 21 CFR Parts 136, 137, and 139. Fed. Regist. 61, 8781-8789 (1996
7. Williams J, Mai CT, Mulinare J, et al. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification -United States, 1995-2011. MMWR Morb. Mortal. Wkly. Rep. 64(1), 1-5 (2015
8. Centers for Disease C, Prevention. Folate status in women of childbearing age, by race/ethnicity -United States, 1999-2000, 2001-2002, and 2003-2004. MMWR Morb. Mortal. Wkly. Rep. 55(51-52), 1377-1380 (2007
9. Blanck HM, Gillespie C, Serdula MK, Khan LK, Galusk DA, Ainsworth BE. Use of low-carbohydrate, high-protein diets among Americans: correlates, duration, and weight loss. MedGenMed 8(2), 5 (2006
10. Quinlivan EP, Gregory JF 3rd. Reassessing folic acid consumption patterns in the United States (1999 2004): potential effect on neural tube defects and overexposure to folate. Am. J. Clin. Nutr. 86(6), 1773-1779 (2007
11. Force USPST. Folic acid for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. Ann. Intern. Med. 150(9), 626-631 (2009
12. Sweeney MR, Staines A, Daly L, et al. Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification? BMC Public Health 9, 295 (2009
13. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 358(9298), 2069-2073 (2001
14. ACOG Committee on Practice Bulletins. ACOG practice bulletin. Clinical management guidelines for obstetriciangynecologists. Number 44, July 2003. (Replaces Committee Opinion Number 252, March 2001). Obstet. Gynecol. 102(1), 203-213 (2003
15. Nutrition in Pregnancy: Scientific Impact Paper No.18 http://www.rcog.org.uk
16. Healthy eating and vitamin supplements in pregnancy. www.rcog.org.uk/globalassets
17. SOGC Clinical PracticeGuideline. No 324. http://sogc.org
18. Kaplan PW, Norwitz ER, Ben-Menachem E, et al. Obstetric risks for women with epilepsy during pregnancy. Epilepsy Behav. 11(3), 283-291 (2007
19. Yerby MS. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology 55(5 Suppl. 1), S21-S31; discussion S54-S28 (2000
20. Hart LA, Sibai BM. Seizures in pregnancy: epilepsy, eclampsia, and stroke. Semin. Perinatol. 37(4), 207-224 (2013
21. Wlodarczyk BJ, Palacios AM, George TM, Finnell RH. Antiepileptic drugs and pregnancy outcomes. Am. J. Med. Genet. A 158A(8), 2071-2090 (2012
22. Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects. Lancet 2(8304), 937 (1982
23. Kallen AJ. Maternal carbamazepine and infant spina bifida. Reprod. Toxicol. 8(3), 203-205 (1994
24. Little BB, Santos-Ramos R, Newell JF, Maberry MC. Megadose carbamazepine during the period of neural tube closure. Obstet. Gynecol. 82(Pt 2 Suppl. 4), 705-708 (1993
25. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N. Engl. J. Med. 324(10), 674-677 (1991
26. ACOG educational bulletin. Seizure disorders in pregnancy. Number 231, December 1996. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Int. J. Gynaecol. Obstet. 56(3), 279-286 (1997
27. Nunes VD, Sawyer L, Neilson J, Sarri G, Cross JH. Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance. BMJ 344, e281 2012
28. Wilson RD, Langlois D, American Congress of Obstetricians and Gynecologists, The Society of Obstetricians and Gynecologists of Canada and The Society of Gynecologic Oncologists of Canada. Genetic considerations for a woman's annual gynaecological examination. J. Obstet. Gynaecol. Can. 34(3), 276-284 (2012
29. Wen SW, Chen XK, Rodger M, et al. Folic acid supplementation in early second trimester and the risk of pre-eclampsia. Am. J. Obstet. Gynecol. 198(1), 45e41-47e41 (2008
30. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe pre-eclampsia. Am. J. Obstet. Gynecol. 185(4), 781-785 (2001
31. Dodds L, Fell DB, Dooley KC, et al. Effect of homocysteine concentration in early pregnancy on gestational hypertensive disorders and other pregnancy outcomes. Clin. Chem. 54(2), 326-334 (2008
32. Makedos G, Papanicolaou A, Hitoglou A, et al. Homocysteine, folic acid and B12 serum levels in pregnancy complicated with pre-eclampsia. Arch. Gynecol. Obstet. 275(2), 121-124 (2007
33. Mujawar SA, Patil VW, Daver RG. Study of serum homocysteine, folic Acid and vitamin b(12) in patients with pre-eclampsia. Indian J. Clin. Biochem. 26(3), 257-260 (2011
34. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 357(9249), 53-56 (2001
35. Sanchez SE, Zhang C, Rene Malinow M, Ware-Jauregui S, Larrabure G, Williams MA. Plasma folate, vitamin B(12), and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. Am. J. Epidemiol. 153(5), 474-480 (2001
36. Sorensen TK, Malinow MR, Williams MA, King IB, Luthy DA. Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of pre-eclampsia. Gynecol. Obstet. Invest. 48(2), 98-103 (1999
37. Van Pampus MG, Dekker GA, Wolf H, et al. High prevalence of hemostatic abnormalities in women with a history of severe pre-eclampsia. Am. J. Obstet. Gynecol. 180(5), 1146-1150 (1999
38. Chuang CZ, Boyles A, Legardeur B, Su J, Japa S, Lopez SA. Effects of riboflavin and folic acid supplementation on plasma homocysteine levels in healthy subjects. Am. J. Med. Sci. 331(2), 65-71 (2006
39. De Bree A, Verschuren WM, Blom HJ, Kromhout D. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am. J. Epidemiol. 154(2), 150-154 (2001
40. Scorsatto M, Uehara SK, Luiz RR, De Oliveira GM, Rosa G. Fortification of flours with folic acid reduces homocysteine levels in Brazilian women. Nutr. Res. 31(12), 889-895 (2011
41. Yamamoto K, Isa Y, Nakagawa T, Hayakawa T. Folic acid fortification ameliorates hyperhomocysteinemia caused by a vitamin B(6)-deficient diet supplemented with L-methionine. Biosci. Biotechnol. Biochem. 76(10), 1861-1865 (2012
42. Bodnar LM, Tang G, Ness RB, Harger G, Roberts JM. Periconceptional multivitamin use reduces the risk of pre-eclampsia. Am. J. Epidemiol. 164(5), 470-477 (2006
43. Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA. Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am. J. Epidemiol. 156(9), 806-812 (2002
44. Li Z, Ye R, Zhang L, Li H, Liu J, Ren A. Folic acid supplementation during early pregnancy and the risk of gestational hypertension and pre-eclampsia. Hypertension 61(4), 873-879 (2013
45. Timmermans S, Jaddoe VW, Silva LM, et al. Folic acid is positively associated with uteroplacental vascular resistance: the Generation R study. Nutr. Metab. Cardiovasc. Dis. 21(1), 54-61 (2011
46. Andres E, Goichot B, Schlienger JL. Food cobalamin malabsorption: a usual cause of vitamin B12 deficiency. Arch. Intern. Med. 160(13), 2061-2062 (2000
47. Elia M. Oral or parenteral therapy for B12 deficiency. Lancet 352(9142), 1721-1722 (1998
48. Victor Hoffbrand A., Daniel Catovsky, Edward GD. Tuddenham and Anthony R.Green. Postgraduate Haematology (6th Edition). Wiley Online Library (2010
49. Rolschau J, Date J, Kristoffersen K. Folic acid supplement and intrauterine growth. Acta Obstet. Gynecol. Scand. 58(4), 343-346 (1979
50. Pritchard JA, McDonald PC. Megaloblastic Anemia (16th Edition). Appelton-Century-Crofts, New York, NY, USA 717 1980
51. Sifakis S, Pharmakides G. Anemia in pregnancy. Ann. NY Acad. Sci. 900, 125-136 (2000
52. Nelen WL, Blom HJ, Steegers EA, Den Heijer M, Thomas CM, Eskes TK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet. Gynecol. 95(4), 519-524 (2000
53. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 95: Anemia in Pregnancy. Obstet. Gynecol. 112, 201 (2008
54. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 134: fetal growth restriction. Obstet. Gynecol. 121, 1122 (2013
55. Baumslag N, Edelstein T, Metz J. Reduction of incidence of prematurity by folic acid supplementation in pregnancy. Br. Med. J. 1(5687), 16-17 (1970
56. Fawzi WW, Msamanga GI, Urassa W, et al. Vitamins and perinatal outcomes among HIV-negative women in Tanzania. N. Engl. J. Med. 356(14), 1423-1431 (2007
57. Goldenberg RL, Tamura T, Cliver SP, Cutter GR, Hoffman HJ, Copper RL. Serum folate and fetal growth retardation: a matter of compliance? Obstet. Gynecol. 79(5 Pt 1), 719-722 (1992
58. Iyengar L, Rajalakshmi K. Effect of folic acid supplement on birth weights of infants. Am. J. Obstet. Gynecol. 122(3), 332-336 (1975
59. Neggers YH, Goldenberg RL, Tamura T, Cliver SP, Hoffman HJ. The relationship between maternal dietary intake and infant birthweight. Acta Obstet. Gynecol. Scand. Suppl. 165, 71-75 (1997
60. Rolschau J, Kristoffersen K, Ulrich M, Grinsted P, Schaumburg E, Foged N. The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I. Eur. J. Obstet. Gynecol. Reprod. Biol. 87(2), 105-110; discussion 103-104 (1999
61. Scholl TO, Hediger ML, Schall JI, Khoo CS, Fischer RL. Dietary and serum folate: their influence on the outcome of pregnancy. Am. J. Clin. Nutr. 63(4), 520-525 (1996
62. Tamura T, Goldenberg RL, Freeberg LE, Cliver SP, Cutter GR, Hoffman HJ. Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome. Am. J. Clin. Nutr. 56(2), 365-370 (1992
63. Ronnenberg AG, Goldman MB, Chen D, et al. Preconception homocysteine and B vitamin status and birth outcomes in Chinese women. Am. J. Clin. Nutr. 76(6), 1385-1391 (2002
64. Lassi ZS, Salam RA, Haider BA, Bhutta ZA. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst. Rev. 3, CD006896 2013
65. Fekete K, Berti C, Trovato M, et al. Effect of folate intake on health outcomes in pregnancy: a systematic review and meta-analysis on birth weight, placental weight and length of gestation. Nutr. J. 11, 75 (2012
66. Timmermans S, Jaddoe VW, Hofman A, Steegers-Theunissen RP, Steegers EA. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. Br. J. Nutr. 102(5), 777-785 (2009
67. Hodgetts VA, Morris RK, Francis A, Gardosi J, Ismail KM. Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis. BJOG 122(4), 478-490 (2015
68. Levy SE, Mandell DS, Schultz RT. Autism. Lancet 374(9701), 1627-1638 (2009
69. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders -Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill. Summ. 61, 1-19 (2012
70. Roth C, Magnus P, Schjolberg S, et al. Folic acid supplements in pregnancy and severe language delay in children. JAMA 306(14), 1566-1573 (2011
71. Suren P, Roth C, Bresnahan M, et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA 309(6), 570-577 (2013
72. O'Roak BJ, State MW. Autism genetics: strategies, challenges, and opportunities. Autism Res. 1(1), 4-17 (2008
73. O'Roak BJ, Vives L, Fu W, et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338(6114), 1619-1622 (2012
74. Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive meta-analysis. Br. J. Psychiatry 195(1), 7-14 (2009
75. Christian P, Murray-Kolb LE, Khatry SK, et al. Prenatal micronutrient supplementation and intellectual and motor function in early school-aged children in Nepal. JAMA 304(24), 2716-2723 (2010
76. Schmidt RJ, Tancredi DJ, Ozonoff S, et al. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am. J. Clin. Nutr. 96(1), 80-89 (2012
77. Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 12(3), 244-252 (2013
78. Meador KJ, Baker GA, Browning N, et al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatrics 168(8), 729-736 (2014
79. Campbell NR. How safe are folic acid supplements? Arch. Intern. Med. 156(15), 1638-1644 (1996
80. Hunter R, Barnes J, Oakeley HF, Matthews DM. Toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet 1(7637), 61-63 (1970
81. Hellstrom L. Lack of toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet 1(7689), 59-61 (1971
82. Richens A. Toxicity of folic acid. Lancet 1(7705), 912 (1971
83. Haberg SE, London SJ, Stigum H, Nafstad P, Nystad W. Folic acid supplements in pregnancy and early childhood respiratory health. Arch. Dis. Child. 94(3), 180-184 (2009
84. Whitrow MJ, Moore VM, Rumbold AR, Davies MJ. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am. J. Epidemiol. 170(12), 1486-1493 (2009
85. Kelly P, Mcpartlin J, Goggins M, Weir DG, Scott JM. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am. J. Clin. Nutr. 65(6), 1790-1795 (1997
86. Dunstan JA, West C, Mccarthy S, et al. The relationship between maternal folate status in pregnancy, cord blood folate levels, and allergic outcomes in early childhood. Allergy 67(1), 50-57 (2012
87. Magdelijns FJ, Mommers M, Penders J, Smits L, Thijs C. Folic acid use in pregnancy and the development of atopy, asthma, and lung function in childhood. Pediatrics 128(1), e135-e144 2011
88. Martinussen MP, Risnes KR, Jacobsen GW, Bracken MB. Folic acid supplementation in early pregnancy and asthma in children aged 6 years. Am. J. Obstet. Gynecol. 206(1), 72 e71-77 e71 (2012
89. Butterworth CE Jr, Hatch KD, Macaluso M, et al. Folate deficiency and cervical dysplasia. JAMA 267(4), 528-533 (1992
90. Charles D, Ness AR, Campbell D, Davey Smith G, Hall MH. Taking folate in pregnancy and risk of maternal breast cancer. BMJ 329(7479), 1375-1376 (2004
91. Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of folate intake and the risk of breast cancer. JAMA 281(17), 1632-1637 (1999
92. Mason JB, Dickstein A, Jacques PF, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol. Biomarkers Prev. 16(7), 1325-1329 (2007
93. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297(21), 2351-2359 (2007
94. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327(26), 1832-1835 (1992
95. Czeizel AE, Vargha P. Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am. J. Obstet. Gynecol. 191(3), 790-794 (2004
96. Ericson A, Kallen B, Aberg A. Use of multivitamins and folic acid in early pregnancy and multiple births in Sweden. Twin Res. 4(2), 63-66 (2001
97. Li Z, Gindler J, Wang H, et al. Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study. Lancet 361(9355), 380-384 (2003